Biomarkers and their application for early detection of severity and prognosis of aneurysmal subarachnoid hemorrhage
A biomarker, subarachnoid technology, applied in the field of molecular diagnosis and molecular biology, to improve the effect of diagnosis and treatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0055]Patient CSF sample acquisition: This study selected 40 patients with CSF specimens of patients with intracranial aneurysms in Thailant Central Hospital in January 2018. This research program is approved by the Ethics Committee of Tai'an Central Hospital (No. 2016-05-003). Patients involved in embolization and aneurysm craniotomy. The severity of damage is referred to the GCS score, hunt-hess grading. The MRS Review Branch was used to follow-up evaluation of the MRS review Branch.
[0056]Incorporate standards and exclusion criteria: (1) between 40 and 70 years old, (2) accepts simple interventional embolism treatment, (3) SAH-liable aneurysm. Excluding criteria: (1) Transfer to craniotherapy in the treatment of craniotomy; (2) SAH caused by multiple responsible aneurysms; (3) blood vessels during surgery; (4) Early cerebral infarction; (5) died within 6 months after surgery. Finally, 18 patients were included. In addition, in this study, we provided 2 cases of clinical case mater...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


